Human complementary reproduction technology is also known as "test-tube-baby" technology. The five medical institutions with their specific work assignments approved by the Ministry of Public Health for "test-tube-baby" technology are as following:

   Reproduction and Genetics Research Institute affiliated with Chongqing Municipal Gynaecology and Obstetrics Hospital; Zhejiang Wenzhou Medical College First Hospital; Jiangsu Nanjing Municipal Gulou Hospital for extraneous insemination-embryo transplanting/ovicell monosperm microscopic injection technology; Gynaecology and Obstetrics Hospital of Zhejiang University for supplied sperm artificial, extraneous insemination, embryo transplanting/ovicell monosperm microscopic injection and prior transplanting embryo genetics diagnostic technology; Jiangsu Province People's Hospital for supplied sperm artificial, extraneous insemination-embryo transplanting/ovicell monosperm microscopic injection technology. Also approved with these are sperm banks by Chongqing Municipal Family Planning Scientific Research Institute Attached Hospital and Jiangsu People's Hospital.

   A survey by relevant departments of the health ministry tells that found already in operation are 44 sperm banks, 175 institutions for "test-tube-baby" technology research, 126 for supplied sperm artificial insemination, 214 institutions for husband-artificial insemination. These make a total of 400 to 500 researching on complementary reproduction technology in China. Making sure that complementary reproduction technology be applied on proper recipients, multiple or twin embryo averted, and less ethic, moral and legal negative impacts produced on women and children, a strict entry system will be enforced in China. It is stressed that human complementary reproduction technology must be carried out on the campuses of approved or registered medical institutions and all the others would likewise be completely forbidden by the Ministry of Public Health in the People's Republic.